Biotech

All Articles

Former Seagen chief executive officer unveils brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for an en...

Ironwood makes additional purpose $1B GI medicine along with brand-new subgroup information

.On the heels of a stage 3 succeed that stopped working to blow away financiers, Ironwood Pharmaceut...

Novartis inks $150M offer for autoimmune molecular glue

.Do not cease Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball aft...

Jade carves out officer crew along with Chinook vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings an...

Septerna goes social with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie creates Richter wealthier, paying out $25M to create discovery treaty

.AbbVie has returned to the resource of its own antipsychotic goliath Vraylar seeking one more runaw...

GenSight goes into ultimate weeks of money runway as profits stream squeezes by of reach

.GenSight Biologics is weeks far from losing loan. Again. The biotech only possesses enough cash to ...

AZ licenses thrown away rare ailment medication to Monopar Rehabs

.Monopar Rehabs is actually bouncing back a medicine coming from the dump of AstraZeneca's rare dise...

Arcus' new HIF-2a data in renal cancer cells mean potential upper hand over Merck's Welireg, professionals claim

.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts ...

Roche bets up to $1B to expand Dyno gene treatment shipping treaty

.After forming a genetics therapy partnership with Dyno Rehabs in 2020, Roche is back for even more....